image credit: Unsplash

Potential Biomarker Discovered for Diagnosing Early-Stage Cancer

Aesop, the Greek fabulist and storyteller, coined the phrase “good things come in small packages.” Now a team of researchers from Memorial Sloan Kettering (MSK) and Weill Cornell Medicine report that extracellular vesicles and particles (EVPs)—tiny packages of materials released by tumors and immune cells—may serve as biomarkers for diagnosing early-stage cancer.

Their study, “Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers,” is published in the journal Cell.

Read More on Genetic Engineering and Biotechnology News